Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 8,000 shares at $31.99 ($256K) on 2014-10-22, disclosed to the SEC on 2014-10-23.
Scheduled sale ($256k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |
| SGNT | SELL | 2014-08-29 | $435K | — | Filing → |